Ipamorelin-induced GH release drives hepatic IGF-1 production and IGF-1 axis activation through the same GH-IGF-1 axis biology engaged by non-selective GH secretagogues and but does so without prolactin-mediated IGF-1 production confounds that arise from GHRP-6 and GHRP-2s co-stimulation of pituitary prolactin
People who participate in physical activities may require alteration regarding the duration of their exercise or moments when they are physically exerting themselves
Early trial data showed approximately 13% weight loss at 12 weeks, a pace that projects to potentially 25-30%+ at full treatment duration
GLP-1 side effects should be discussed with a doctor when nausea, constipation, vomiting, reflux, fatigue, dizziness, abdominal pain, dehydration, or poor intake interferes with daily life, prevents the patient from eating enough protein or drinking enough fluid, worsens after a dose increase, persists for more than a short adjustment period, or feels severe or unusual